CD8A and pancreatic neoplasm: In an orthotopic organoid model of pancreatic cancer, combination therapy involving CD40 antibodies (CD40Ab) and irreversible electroporation (IRE) improved the recognition of neoantigens by DCs, subsequently triggering a robust CD8+ T cell response that facilitated tumour control.121